S753 Pharmacovigilance Data on Pregnancy Outcomes in Women With Crohn’s Disease Exposed to Certolizumab Pegol
Clowse, Megan E., Dubinsky, Marla C., Fischer-Betz, Rebecca, Nelson-Piercy, Catherine, Scheuerle, Angela E., Stephan, Brigitte, Kumke, Thomas, Kasliwal, Rachna, Lauwerys, Bernard, Förger, Frauke
Published in The American journal of gastroenterology (01.10.2021)
Published in The American journal of gastroenterology (01.10.2021)
Get full text
Journal Article
Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol
Clowse, Megan, Fischer-Betz, Rebecca, Nelson-Piercy, Catherine, Scheuerle, Angela E., Stephan, Brigitte, Dubinsky, Marla, Kumke, Thomas, Kasliwal, Rachna, Lauwerys, Bernard, Förger, Frauke
Published in Therapeutic advances in musculoskeletal disease (01.04.2022)
Published in Therapeutic advances in musculoskeletal disease (01.04.2022)
Get full text
Journal Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Ryerson, Lana Zhovtis, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan R, Goldberg, Judith D, Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Kasliwal, Rachna, Ren, Zheng, Hotermans, Christophe, Ho, Pei-Ran, Campbell, Nolan
Published in Neurology (08.10.2019)
Published in Neurology (08.10.2019)
Get more information
Journal Article
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
Butzkueven, Helmut, Kappos, Ludwig, Wiendl, Heinz, Trojano, Maria, Spelman, Tim, Chang, Ih, Kasliwal, Rachna, Jaitly, Seema, Campbell, Nolan, Ho, Pei-Ran, Licata, Stephanie
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2020)
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2020)
Get full text
Journal Article
Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial
Elkind, Mitchell S V, Veltkamp, Roland, Montaner, Joan, Johnston, S Claiborne, Singhal, Aneesh B, Becker, Kyra, Lansberg, Maarten G, Tang, Weihua, Kasliwal, Rachna, Elkins, Jacob
Published in Neurology (25.08.2020)
Published in Neurology (25.08.2020)
Get more information
Journal Article
199 Changes in natalizumab exposure and PML incidence over time
Giovannoni, Gavin, Kappos, Ludwig, Berger, Joseph, Cutter, Gary, Fox, Robert, Wiendl, Heinz, Chang, Ih, Kasliwal, Rachna, Lee, Lily
Published in Journal of neurology, neurosurgery and psychiatry (01.12.2019)
Published in Journal of neurology, neurosurgery and psychiatry (01.12.2019)
Get full text
Journal Article
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis
Foley, John, Carrillo-Infante, Cynthia, Smith, Jonathan, Evans, Karleyton, Ho, Pei-Ran, Lee, Lily, Kasliwal, Rachna, Stangel, Martin, Vermersch, Patrick, Hutchinson, Michael, Marinelli, Fabiana, Smirnakis, Karen
Published in Multiple sclerosis and related disorders (01.04.2020)
Published in Multiple sclerosis and related disorders (01.04.2020)
Get full text
Journal Article
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time
Giovannoni, Gavin, Kappos, Ludwig, Berger, Joseph, Cutter, Gary, Fox, Robert J., Wiendl, Heinz, Chang, Ih, Kasliwal, Rachna, Lee, Lily, Licata, Stephanie, Ho, Pei-Ran
Published in Revue neurologique (01.04.2019)
Published in Revue neurologique (01.04.2019)
Get full text
Journal Article
Real-world data from over 10 years in the TYSABRI® Observational Program: Long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients
Kappos, Ludwig, Butzkueven, Helmut, Spelman, Tim, Trojano, Maria, Wiendl, Heinz, Jiang, Xiaoyu, Kasliwal, Rachna, Campbell, Nolan, Ho, Pei-Ran, Licata, Stephanie
Published in Revue neurologique (01.04.2019)
Published in Revue neurologique (01.04.2019)
Get full text
Journal Article
Hypoglycaemia with Oral Antidiabetic Drugs: Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide
Vlckova, Veronika, Cornelius, Victoria, Kasliwal, Rachna, Wilton, Lynda, Shakir, Saad A. W.
Published in Drug safety (01.01.2009)
Published in Drug safety (01.01.2009)
Get full text
Journal Article